Director/PDMR Shareholding
Amryt Pharma plc
Director/PDMR Shareholding
The following notification is made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018).
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Ray Stafford
2
Reason for the notification
a)
Position/status
Chairman
b)
Initial Notification Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Amryt Pharma plc
b)
LEI
213800YNUJEOJ8L4T95
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
American Depositary Shares
US03217L1061
b)
Nature of the transaction
Purchase of Shares
c)
Price(s) and volume(s)
Price(s) | Volume(s) |
$9.40 | 50,000 ADSs |
d)
Aggregated information
— Aggregated volume
— Price
N/A – single transaction
e)
Date of the transaction
November 29, 2021
f)
Place of the transaction
NASDAQ
Contacts |
